Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry

British Journal of Cancer

Volumn 77, Issue 10, 1998, Pages 1638-1641

  Kennedy, S ^a,b   Duffy, M J ^b   Duggan, C ^b   Barnes, C ^a   Rafferty, R ^b   Kramer, M D ^c  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast carcinoma; Immunocytochemistry; Urokinase plasminogen activator; Urokinase plasminogen activator receptor

Indexed keywords

CELL MARKER; CYTOKERATIN; MONOCLONAL ANTIBODY; UROKINASE; UROKINASE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INVASIVE CARCINOMA; MACROPHAGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINDLE CELL; STROMA CELL;

EID: 0031982261     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.268     Document Type: Article

References (22)

1. Andreasen PA, Kjoøller L, Christensen L and Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22
2. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM and Kramer MD (1996) Upregulation of cell-surface associated plasminogen activation in cultured keratinocytes by interleukin-1β and tumor necrosis factor-α. Exp Cell Res 233: 395-404
3. Bianchi E, Cohen RL, Thor AT, Todd RF III, Mizukami F, Lawrence DA, Ljung BM, Shuman MA and Smith HS (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54: 861-866
4. Boros P and Miller CM (1995) Hepatocyte growth factor: a multifunctional cytokine. Lancet 354: 293-295
5. Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP and Sulvatore M (1994) Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 54: 5445-5454
6. 2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66: 441-452
7. Danø K, Behrendt N, Brunner N, Ellis V, Ploug M and Pyke C (1994) The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8: 189-203
8. Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G and Esposito G (1993) Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 53: 3198-3206
9. de Vries TJ, Quax PHA, Denijn M, Verijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ and van Muijen GNP (1994) Plasminogen activators, their inhibitors and urokinase receptor emerge in late stage of melanocytic tumor progression. Am J Pathol 144: 70-81
10. Duffy MJ (1992) The role of proteolytic enzimes in cancer invasion and metastasis. Clin Exp Metastasis 10: 145-155
11. Duffy MJ (1993) Urokinase-type plasminogen activator and malignancy. Fibrinolysis 7: 295-302
12. Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2: 613-618
13. Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ and Duffy MJ (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 61: 597-600
14. Escot C, Zhao Y, Puech C and Rochefort H (1996) Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3. and urokinase plasminogen activator RNAs in breast cancer. Breast Cancer Treat 38: 217-226
15. Groøndahl-Hansen J, Peters H, Kirkeby J, van Putten WLJ, Look MP, Pappot H, Roønne E, Danoø K, Klijn JGM, Brünner N and Foekens JA (1995) Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res 1: 1079-1087
16. Jäincke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H and Graeff H (1993) Urokinase (uPA) and its inhibitor PAI-I are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208
17. Jankun J, Merrick HW and Goldblatt PJ (1993) Expression and localisation of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 53: 135-144
18. Mars WM, Zarnegar R and Michalopoulos GL (1993) Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 143: 949-958
19. Nielsen BS, Sebested M, Timshel S, Pyke C and Dano K (1996) Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest 74: 168-177
20. Pyke C, Kristensen P, Ralfkiaer E, Groøndahl-Hansen J, Eriksen J, Blasi F and Dano K (1991) uPA is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am J Pathol 138: 1059-1067
21. Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brünner N and Dano K (1993) Receptor for urokinase is present in tumour-associated macrophages in ductal breast carcinoma. Cancer Res 53: 1911-1915
22. Schaefer BM, Maier K, Fickhoff U, Todd RF and Kramer MD (1994) Plasminogen activation in healing human wounds. Am J Pathol 144: 1269-1280